Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Galera Therapeutics, Inc. - Common Stock (NQ: GRTX )

0.1450 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.1450
Bid (Size) 0.1379 (311)
Ask (Size) 0.1380 (130)
Prev. Close 0.1450
Today's Range 0.1450 - 0.1450
52wk Range 0.1290 - 0.2900
Shares Outstanding 43,928,666
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GRTX Stock Earnings: Galera Therapeutics Reported Results for Q2 2024
Galera Therapeutics just reported results for the second quarter of 2024. 
Via InvestorPlace
Galera Announces Board Approval of Complete Liquidation and Dissolution
Company reports second quarter 2024 financial results 
From Galera Therapeutics
Via GlobeNewswire

Performance

YTD
-4.61%
-4.61%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+5.45%
+5.45%

More News

Read More
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Galera Therapeutics (GRTX) Stock Is Nosediving
Via Benzinga
Galera Therapeutics: Q4 Earnings Insights
Via Benzinga
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
GRTX Stock Earnings: Galera Therapeutics Reported Results for Q1 2024
Via InvestorPlace
Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates
From Galera Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Galera Adopts Limited Duration Stockholder Rights Agreement
From Galera Therapeutics
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
GRTX Stock Earnings: Galera Therapeutics Beats EPS for Q4 2023
Via InvestorPlace
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
From Galera Therapeutics
Via GlobeNewswire
Why TransMedics Group Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Galera Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.